VO2max and Mortality: What the Association Really Means

In the largest analysis of its kind, higher cardiorespiratory fitness tracked with dramatically lower long-term mortality, and the survival advantage kept rising with fitness, showing no ceiling. That finding, published in JAMA Network Open in 2018, is real and consistent, but it is observational, which means it can show that fit people live longer without proving that getting fitter is what makes them live longer. The same numbers are compatible with fitness protecting the body, with healthier biology producing higher fitness, or with both happening at once. Reading the study well means separating what it measured from what it can conclude.

The dataset behind the headlines

Kyle Mandsager and colleagues at the Cleveland Clinic analyzed 122,007 consecutive adults referred for symptom-limited treadmill testing. They graded each person's peak exercise capacity in metabolic equivalents (METs), then sorted people into age- and sex-specific percentiles: low, below average, above average, high, and elite (at or above the 97.7th percentile, roughly two standard deviations above the mean). Over about 1.1 million person-years and a median follow-up near 8.4 years, 13,637 people died.

The gradient was steep. Compared with elite performers, the lowest-fitness group carried about five times the adjusted risk of death (adjusted hazard ratio 5.04), while elite fitness was tied to roughly one-fifth the risk of the low group (adjusted hazard ratio 0.20). Even the step from high to elite fitness left a measurable survival edge. The authors calculated that the mortality risk linked to poor fitness was comparable to or greater than that of coronary artery disease, diabetes, or smoking. Low fitness, in other words, behaved like a major risk factor.

One technical point matters for interpretation. Fitness here was estimated from treadmill workload, a close proxy for VO2max rather than the directly measured gas-exchange value. The percentile framing, not an absolute laboratory number, carried the analysis.

"No upper limit of benefit," carefully read

The line that traveled furthest was that fitness showed no observed upper limit of benefit. Within this population, higher percentiles kept associating with lower mortality, with no plateau and no U-shaped uptick at the extreme. That is a meaningful rebuttal to the worry that very high training loads might backfire, at least for all-cause survival in this cohort.

But "no upper limit of benefit" describes the shape of a curve, not a dose anyone can prescribe. It says the association did not flatten. It does not say that moving a specific person from high to elite fitness will subtract a predictable number of years from that person's own risk. A population-level gradient and an individual guarantee are different objects.

Why an association is not a verdict on cause

Three well-known problems keep observational fitness data from proving cause.

Reverse causation. Subclinical disease lowers exercise capacity long before it is diagnosed. Early heart failure, an undetected cancer, or creeping frailty can quietly drag down fitness years ahead of death. In that sequence, low fitness is a symptom of the illness that kills, not its cause. Because fitness was measured once, the study cannot see this history.

Confounding. People who test as highly fit differ from those who do not in many ways at once: they smoke less, tend toward better diets, carry different genetics, and often have more resources. Statistical adjustment handles the factors that were measured. The authors openly flag the ones that were not, including socioeconomic status and race or ethnicity.

Selection. Everyone in this cohort was sent for a stress test, so this is a clinical population, not a cross-section of the public. Mandsager and colleagues state directly that the association does not prove causation, and that observational data cannot tell us how much of the survival edge reflects fitness itself versus healthier people being fit to begin with.

What proving causation would require

The cleanest test, randomizing thousands of people to decades of high versus low fitness, is not feasible, as the authors acknowledge. Causal confidence therefore comes from convergence rather than a single trial. Exercise-training studies show that VO2max is trainable and that raising it improves blood pressure, glucose handling, and other intermediate markers. The biological mechanisms are plausible. Yet no trial has randomized fitness itself and then counted deaths over a lifetime, so the final link from a higher number to more years remains inferred, not demonstrated.

This is why the American Heart Association, in its 2016 scientific statement, argued for treating cardiorespiratory fitness as a clinical vital sign. Its case rested on prediction: fitness forecasts cardiovascular and all-cause mortality about as powerfully as hypertension, smoking, or diabetes. A strong predictor is genuinely useful, and it is still a different claim from a proven lever you can pull.

Reading fitness claims without overreaching

Two things can be true together. Fitness is among the strongest predictors of mortality we have, and that is settled. Whether a particular supplement, protocol, or wearable that promises to "raise your VO2max" buys you extra years is a separate question that most such products have never tested. Prediction is not a personal guarantee of return.

The honest verdict is not skepticism for its own sake. The convergence of trainability, a consistent dose-response, and plausible biology makes regular aerobic activity one of the better-supported health behaviors we have, even if the exact number of years it adds to any one life stays uncertain. This article is educational and is not medical advice.